Filing Details

Accession Number:
0001181431-11-026368
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-02 16:31:35
Reporting Period:
2011-04-28
Filing Date:
2011-05-02
Filing Date Changed:
2011-05-02
Accepted Time:
2011-05-02 17:31:35
Original Submission Date:
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325879 Aveo Pharmaceuticals Inc AVEO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1486420 A Ronald Depinho C/o Aveo Pharmaceuticals, Inc.
75 Sidney Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings
Common Stock Disposition 2011-04-28 10,000 $14.70 240,012
Common Stock Disposition 2011-04-28 10,000 $15.53 230,012
Common Stock Disposition 2011-04-28 10,000 $14.69 232,512
Common Stock Disposition 2011-04-28 10,000 $15.53 222,512
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Indirect by spouse
No 4 S Indirect by spouse
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2011.
  2. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.50 to $14.88, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  3. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.50 to $15.59, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  4. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on March 8, 2011.
  5. These shares are held by the reporting person's spouse. The reporting person disclaims all beneficial ownership over all such shares, except to the extent of his pecuniary interest therein.
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 30 percentage points in 13 months Learn how!

Billionaire Hedge Funds
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!